Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions
US4757056A · kind A · utility
25Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1985 |
| Grant date | Jul 12, 1988 |
| Priority date | — |
| Expiry date | Apr 26, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/715
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Regression of established malignant tumors in rats, mice and hamsters is achieved with a combination of the heparin fragment hexuronyl hexosaminoglycan sulfate (HHS) together with a steroid such as hydrocortisone. HHS is clinically useful for its antineoplastic, inhibiting effects in tumor systems in rats, mice and hamsters.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.